21st Century Necromancer-Chapter 512 - 508

Although Daimon Michiko told Chen Yu not to take her position as the chief surgeon, she knew very well that she could not complete the surgery by herself.

The Inferior Vena Cava is the largest vein in the human body and has a significant impact. If the patient's tumor is located at this site, the surgery not only is difficult but also has high risks, and the slightest carelessness could lead to very serious consequences.

Especially in the patient's previous examination results, it was clear to see that the abdominal mass had affected the liver, kidneys, and several major blood vessels. Should major bleeding occur during surgery, it could very likely endanger the patient's life.

Such a complex surgery, if performed by ordinary doctors, might even require two surgical teams to take turns in a relay to have enough energy and strength to complete it.

"If you, Doctor Chen Yu, were to be the chief surgeon, what method would you use to complete this surgery?" Daimon Michiko, though confident in her own surgical abilities, did not believe she could finish the surgery alone. If possible, she actually wanted Chen Yu to act as her assistant to help her complete the surgery.

Hearing Daimon Michiko ask this, Chen Yu touched his nose and, after carefully reviewing the patient's medical record again, said, "The specific examination results haven't come out yet, so I can't make a conclusive decision, but if surgery on the tumor at the location of the Inferior Vena Cava is to be performed, I would opt for an extracorporeal circulation for the resection of the downstream Inferior Vena Cava and then treat it by transplanting an artificial blood vessel.

However, this operation might likely require the resection and autologous transplantation of the liver and kidneys. Yet, liver resection after the removal of the Inferior Vena Cava tumor and autologous liver and kidney transplants have only two successful cases worldwide. Daimon-san, are you thinking of taking on this challenge?"

"It's not about taking on a challenge, but about healing the patient," Daimon Michiko, though addicted to performing surgeries, was very serious about treating patients: "And I will not fail!"

"It's not something that can be dismissed by just claiming there will be no failure, but let's wait for the patient's examination results first. Perhaps autologous liver and kidney transplants won't be necessary?" Although Chen Yu remained optimistic, looking at the examination results on the medical record, he was not optimistic about this surgery.

————————————————

It was another week's preoperative seminar, and the first case to be presented was the one that Chen Yu and Daimon Michiko had discussed before.

"The patient, Murata Kouta-san, a 42-year-old male. The patient sought medical treatment at a local hospital for abdominal pain and swelling of the lower extremities, and the swelling was alleviated after taking diuretic medications. However, a mass in the Inferior Vena Cava was discovered upon examination at the local hospital. After examining at our hospital, it was confirmed to be a leiomyosarcoma of the Inferior Vena Cava, with the attending physician being Doctor Daimon Michiko."

"This patient is my patient. After a CT scan, it was confirmed that behind the patient's liver, from the entrance of the renal vein to the Inferior Vena Cava to the entrance of the atrium, there is a fifteen-centimeter-long tumor, and it has already caused hepatic vein obstruction and possibly invaded the Right Hepatic Vein and Right Renal Vein." Daimon Michiko stood up, walked to the screen, and pointed at the CT images on it as she explained.

Such a degree of tumor is very rare even for the doctors at the Tokyo University Medical School Hospital. After Daimon Michiko finished her explanation, a sharp intake of breath could be heard in the conference room, clearly everyone was shocked by the severity of the tumor.

At this point, an internist stood up and said, "A tumor of this degree is no longer suitable for surgical removal. I suggest that the patient should be transferred to our department for conservative treatment, prioritizing the patient's survival time and quality of life."

"Now that Professor Chen Yu has developed a broad-spectrum anti-cancer drug, it can ensure the survival time and quality of life of patients with tumors like this one well. There's no need to take such a big risk to operate on the patient."

Although internal medicine and surgery are traditionally at odds, in the face of Chen Yu's invention of the broad-spectrum anti-cancer drug, internists had to admit that it was a very effective treatment for cancer. Although it couldn't cure the disease, as long as one kept taking it, it could suppress the cancer. This was nothing short of a godsend for those with terminal cancer, and despite their reluctance, internists had to use this drug.

However, the drug was not yet officially on the market; they could only get a limited number of treatment slots from Chen Yu under the guise of clinical trials, limiting the use of the drug.

But when Chen Yu heard the internist's words, he stood up to object, "The initial intent of my research on the broad-spectrum anti-cancer drug was to cure cancer, not just to suppress it. As doctors, if we choose to evade because of the high difficulty of surgery, how can we live up to those patients who entrust their lives to us, and how can we promote the development of medicine?"

This chapt𝓮r is updat𝒆d by ƒreeωebnovel.ƈom.

Hearing Chen Yu's words, the internist was immediately put in an awkward position and did not know how to retort, so he had to sit down dejectedly.

Chen Yu's words were typical grand truths. Although they sounded very reasonable, they weren't very practical. However, such words are exactly what one cannot refute because no one wants to commit a fundamental mistake. It was precisely because of this that Chen Yu intentionally spoke this way to block the idea of conservative treatment favored by internal medicine.

However, while ordinary internists could not refute Chen Yu's words, Yamamoto Hisae, the head of internal medicine, clearly wouldn't be so easily deterred by Chen Yu's words and immediately questioned him: "Professor Chen Yu, your idea is certainly good, but this surgery is so difficult. The tumor is only one centimeter away from the patient's heart. Professor Chen Yu, are you really confident in completing this surgery? And how do you plan to accomplish such a surgery?"

Yamamoto Hisae didn't refute Chen Yu's statement; she was merely inquiring about the method of surgery. But the implication of her words was clear -- if even a surgical plan could not be proposed, then there's no point in performing the surgery.

But this was not something that could stump Chen Yu. He stood up from his seat, walked to the screen, looked at the patient's CT images, and said to Daimon Michiko beside him: "Just as I expected, liver resection and autotransplantation are necessary!"

"Not only the liver, but the kidneys might also need resection and autotransplantation, given how extensively the tumor has invaded," Daimon Michiko nodded and discussed with Chen Yu how to complete the surgery: "So, an ex vivo liver resection and autotransplantation need to be performed?"

"Yes, through extracorporeal circulation, perform an ex vivo liver resection, autologous liver transplantation, renal vein resection and reconstruction, inferior vena cava excision, and artificial blood vessel transplant surgery to treat the patient's inferior vena cava leiomyosarcoma," Chen Yu listed the surgical steps required and added, "Vascular surgery, hepatobiliary surgery, and organ transplantation surgery are all required to participate in the operation."